We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Shedding Light on How Tumors Become Resistant to Immunotherapy

News   Jul 26, 2017 | Original story from University of Zurich

 
Shedding Light on How Tumors Become Resistant to Immunotherapy

The epigenetic control protein Ezh2 plays a central role in how cancer cells develop resistance. (Bild: D. Zingg, UZH)

 
 
 

RELATED ARTICLES

New “Jekyll and Hyde” Immune Cell Discovered

News

Scientists have identified a rare, new cell that plays a key protective role in immunity to infection but – if unregulated – can also mediate tissue damage in autoimmune disorders.

READ MORE

Research Outlines How Drug in Clinical Trial for Coronavirus Works

News

A new study published in the Journal of Biological Chemistry outlines how an antiviral drug that is currently being tested in patients with the novel coronavirus (COVID-19), remdesivir, works.

READ MORE

Existing Drugs Could Be Key To Combatting Coronavirus Outbreak

News

Developing new drugs and vaccines to treat the coronavirus that causes COVID-19 can take years. Existing drugs may offer a possible quick response to the potential pandemic.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE